Dr. Frimpong to Leave Temple Effective May 6, 2022
Justina Frimpong, PharmD, BCOP, Clinical Assistant Professor, will leave the Temple University School of Pharmacy effective May 6, 2022. She has accepted a position as a Senior Oncology Medical Science Liaison on the Targeted Medicines Team at Bayer Pharmaceuticals covering the Pennsylvania, New Jersey, and New York territories.
In October of 2016, Dr. Frimpong joined the Pharmacy Practice faculty. As part of her role, she has practiced with the Medical Oncology group at the Temple University Hospital Cancer Center utilizing her training and credentials as a Board Certificated Certified Oncology Pharmacist.
Dr. Frimpong has been an active participant in the PREP program for incoming PY1 Doctor of Pharmacy students. She has provided lectures on oncology-related topics to the Oncology Fellows as well as Internal Medicine Residents at Temple University Hospital.
A tirelessly active and engaged pharmacy professional and faculty member, Dr. Frimpong has served as a volunteer for various projects and committees in national and local organizations. She served on various committees within the Hematology/Oncology Pharmacy Association (HOPA), including on the Diversity, Equity and Inclusion Taskforce, Annual Conference Breakout Session Subcommittee, and Research Abstract Review Workgroup Subcommittee and as a Board-Certified Oncology Pharmacist Field Tester. She has served as an elected Board Member-at-Large for the Delaware Valley Society of Health-Systems Pharmacists Association for the past four years. For Temple University Hospital, she has served as a member of the Infusion Center Committee, Cancer Committee, and Chemotherapy Safety Committee. For the school, she has served as a co-advisor for the Student Society of Health-System Pharmacists (SSHP) and was critical in the coordination of SSHP’s Clinical Skills Competition and Mentor Night events. She also recently served as faculty advisor of the National Community Oncology Dispensing Association.
Dr. Frimpong received her Doctor of Pharmacy degree from the Philadelphia College of Pharmacy at the University of the Sciences in Philadelphia. She subsequently completed postgraduate residencies in Pharmacy Practice (PGY-1) at St. Joseph Medical Center at Penn State Health in Reading, Pa. and Oncology Pharmacy (PGY-2) at H. Lee Moffitt Cancer Center & Research Institute on the University of South Florida campus in Tampa, Fl.